ZA886216B - Novel aristeromycin/adenosine derivatives - Google Patents

Novel aristeromycin/adenosine derivatives

Info

Publication number
ZA886216B
ZA886216B ZA886216A ZA886216A ZA886216B ZA 886216 B ZA886216 B ZA 886216B ZA 886216 A ZA886216 A ZA 886216A ZA 886216 A ZA886216 A ZA 886216A ZA 886216 B ZA886216 B ZA 886216B
Authority
ZA
South Africa
Prior art keywords
aristeromycin
novel
adenosine derivatives
adenosine
derivatives
Prior art date
Application number
ZA886216A
Other languages
English (en)
Inventor
Esa T Jarvi
T Jarvi Esa
James R Mccarthy
R Mccarthy James
Nellikunja J Prakash
J Prakash Nellikunja
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA886216B publication Critical patent/ZA886216B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052Imidazole radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056Triazole or tetrazole radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA886216A 1987-08-26 1988-08-22 Novel aristeromycin/adenosine derivatives ZA886216B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8969387A 1987-08-26 1987-08-26

Publications (1)

Publication Number Publication Date
ZA886216B true ZA886216B (en) 1989-04-26

Family

ID=22219090

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA886216A ZA886216B (en) 1987-08-26 1988-08-22 Novel aristeromycin/adenosine derivatives

Country Status (22)

Country Link
US (1) US4997924B1 (xx)
EP (1) EP0304889B1 (xx)
JP (1) JP2722215B2 (xx)
KR (1) KR970002660B1 (xx)
CN (1) CN1023561C (xx)
AR (1) AR244229A1 (xx)
AT (1) ATE141282T1 (xx)
AU (1) AU613660B2 (xx)
CA (1) CA1315779C (xx)
DE (1) DE3855470T2 (xx)
DK (1) DK166355C (xx)
ES (1) ES2092981T3 (xx)
FI (1) FI90876C (xx)
GR (1) GR3020849T3 (xx)
HU (1) HU199153B (xx)
IE (1) IE81117B1 (xx)
IL (1) IL87532A (xx)
NO (1) NO168361C (xx)
NZ (1) NZ225906A (xx)
PH (1) PH25533A (xx)
PT (1) PT88340B (xx)
ZA (1) ZA886216B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996308A (en) * 1988-03-25 1991-02-26 Merrell Dow Pharmaceuticals Inc. Derivatives with unsaturated substitutions for the 5'-hydroxymethyl group
HU204843B (en) * 1988-09-27 1992-02-28 Merrell Dow Pharma Process for producing 2'-halogen-methylidene adenosine derivatives and pharmaceutical compositions comprising same
JPH02215781A (ja) * 1989-02-14 1990-08-28 Toyo Jozo Co Ltd 6’―デオキシ―6’―ハロゲノネプラノシンaおよびその製造法
IL95165A0 (en) * 1989-07-24 1991-06-10 Glaxo Group Ltd Cyclopentane derivatives
AU632856B2 (en) * 1989-10-11 1993-01-14 Merrell Dow Pharmaceuticals Inc. Novel inosine/guanosine derivatives
ZA907998B (en) * 1989-10-11 1991-07-31 Merrell Dow Pharma Inosine/guanosine derivatives as antineoplastic agents
ZA908001B (en) * 1989-10-11 1991-08-28 Merrell Dow Pharma Inosine/guanosine derivatives as immunosuppressive agents
DE4005275A1 (de) * 1990-02-20 1991-08-22 Grundmann Ewald Verwendung von s-adenosylmethionin als mittel gegen virale infektionen durch retroviren
JPH0421682A (ja) * 1990-05-11 1992-01-24 Asahi Chem Ind Co Ltd 2―フルオロネプラノシンaおよびその製造法
US5618704A (en) * 1990-07-27 1997-04-08 Isis Pharmacueticals, Inc. Backbone-modified oligonucleotide analogs and preparation thereof through radical coupling
ZA916350B (en) * 1990-08-16 1992-05-27 Merrell Dow Pharma 5'-vinylhalo-aristeromycin/adenosine analogs as immunosuppressants
US5244896A (en) * 1990-09-14 1993-09-14 Marion Merrell Dow Inc. Carbocyclic adenosine analogs useful as immunosuppressants
US5514688A (en) * 1990-09-14 1996-05-07 Merrell Dow Pharmaceuticals Inc. Carbocyclic adenosine analogs useful as immunosuppressants
US5206244A (en) * 1990-10-18 1993-04-27 E. R. Squibb & Sons, Inc. Hydroxymethyl (methylenecyclopentyl) purines and pyrimidines
US5696097A (en) * 1993-03-18 1997-12-09 Yamasa Corporation Antineoplastic 5'-diacylglycerylphosphatidyl-2-deoxy-2'-methylenylcytidines and method of making
EP0630897A3 (en) * 1993-06-25 1995-03-01 Bristol Myers Squibb Co 3-hydroxy-4-hydroxymethyl-2-methylene-cyclopentyl purines and pyrimidines.
US6579857B1 (en) * 1999-06-11 2003-06-17 Evanston Northwestern Healthcare Research Institute Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928319A (en) * 1971-06-16 1975-12-23 Syntex Inc 4 -Fluoro nucleosides, novel intermediates and methods of preparing same
US3910885A (en) * 1974-03-12 1975-10-07 Syntex Inc 4-Alkoxy nucleosides and intermediates therefore
JPS5651414A (en) * 1979-10-02 1981-05-09 Toyo Jozo Co Ltd Antibiotic substance neplanocin preparation
US4543255A (en) * 1984-05-10 1985-09-24 Southern Research Institute Carbocyclic analogs of purine 2'-deoxyribofuranosides

Also Published As

Publication number Publication date
IE882593L (en) 1989-02-26
DE3855470D1 (de) 1996-09-19
AU2143888A (en) 1989-03-02
JPH01308267A (ja) 1989-12-12
US4997924A (en) 1991-03-05
NZ225906A (en) 1990-10-26
PH25533A (en) 1991-07-24
ATE141282T1 (de) 1996-08-15
IE81117B1 (en) 2000-03-22
NO883793D0 (no) 1988-08-25
EP0304889B1 (en) 1996-08-14
JP2722215B2 (ja) 1998-03-04
GR3020849T3 (en) 1996-11-30
US4997924B1 (en) 1995-11-14
CA1315779C (en) 1993-04-06
FI883889A (fi) 1989-02-27
FI883889A0 (fi) 1988-08-23
NO168361B (no) 1991-11-04
EP0304889A2 (en) 1989-03-01
NO168361C (no) 1992-02-12
KR970002660B1 (en) 1997-03-07
HU199153B (en) 1990-01-29
HUT47954A (en) 1989-04-28
IL87532A (en) 1993-05-13
AU613660B2 (en) 1991-08-08
PT88340B (pt) 1995-05-04
ES2092981T3 (es) 1996-12-16
NO883793L (no) 1989-02-27
EP0304889A3 (en) 1990-01-24
CN1023561C (zh) 1994-01-19
CN1033632A (zh) 1989-07-05
PT88340A (pt) 1989-06-30
IL87532A0 (en) 1989-01-31
DK166355B (da) 1993-04-13
FI90876B (fi) 1993-12-31
DK166355C (da) 1993-09-06
FI90876C (fi) 1994-04-11
DK475488D0 (da) 1988-08-25
DE3855470T2 (de) 1997-03-13
KR890003796A (ko) 1989-04-18
DK475488A (da) 1989-02-27
AR244229A1 (es) 1993-10-29

Similar Documents

Publication Publication Date Title
GB2212498B (en) Adenosine derivatives
IL84414A0 (en) N9-cyclopentyl-substituted adenine derivatives
KR970002660B1 (en) Novel aristeromycin/adenosine derivatives
GB2213146B (en) Pyrimidine derivatives
GB2208860B (en) Pyrimidine derivatives
PH25577A (en) Purine derivatives
GB8712115D0 (en) Pyrimidine derivatives
EP0317175A3 (en) Pyrimidine derivatives
GB8827462D0 (en) Pyrimidine derivatives
GB2209525B (en) Pyrimidine derivatives
GB8725466D0 (en) Purine derivatives
JPS6429395A (en) Adenosine compound
IE870359L (en) Purine derivatives
IE862197L (en) Guanine derivatives
IE863242L (en) Guanine derivatives
GB8702931D0 (en) Pyrimidine derivatives
GB8715684D0 (en) Pyrimidine derivatives
GB8719694D0 (en) Pyrimidine derivatives
GB8729583D0 (en) Pyrimidine derivatives
GB8608180D0 (en) Purine derivative
IE870520L (en) Isohexide nucleoside